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Human papillomavirus types 2 (HPV-2), HPV-27, and HPV-57, are three closely related viruses within the phylogenetic
supergroup formed by the remotely related genital papillomaviruses. In contrast to this phylogenetic association, these three
viruses are most often found in common warts at nongenital sites, but also occasionally in genital warts and mucosal lesions
of the nasopharyngeal cavity. We studied the genomic diversity of HPV sequences in skin warts presumably caused by these
viruses. These biopsies were sampled from 75 patients living in Germany, Japan, or Singapore. Among 27 warts with HPV-2,
we found seven new genomic variants and among 32 with HPV-57, eight new variants. In both cases, we did not detect the
original prototype genomes. In contrast, 13 of 16 warts with HPV-27 contained the prototype genome, and only one new
variant was found in three patients. We did not find variants clearly intermediate between any two types, although HPV-2 and
HPV-27 are among the most closely related of the extent HPV types. We also did not detect novel HPV types, although the
samples were examined with polymerase chain reaction protocols that would have detected remotely related HPVs. So we
propose that the phylogenetic group formed by HPV-2, HPV-27, and HPV-57 has no or only very rare additional members. One
of the HPV-57 variants found, HPV-57-G44, was most likely identical to the subtype HPV-57b, previously proposed to be
associated with nasal neoplasia, but found here frequently in common skin warts. Our publication establishes a foundation
for pathological and phylogenetic comparisons of HPV types in skin warts. © 1997 Academic Press
INTRODUCTION
Papillomaviruses (PVs) are a model for a rational tax-
onomy of DNA viruses based on phylogenetic analysis of
the nucleotide sequences of different isolates. PVs are
described as ‘‘types,’’ which is analogous to the term
species. Presently, close to 80 human papillomavirus
(HPV) and 25 animal papillomavirus types have been
isolated and formally described, and most of them have
been completely or partially sequenced (deVilliers, 1994;
Chan et al., 1995; Myers et al., 1996). Powerful protocols
based on polymerase chain reactions with consensus
primers have identified approximately 30 additional PVs
in humans (Bernard et al., 1994; Berkhout et al., 1995;
Shamanin et al., 1996) and animals (Chan et al., 1997) by
nucleotide sequence comparison without the need for
isolation and formal description. The largest standard-
ized database for the comparison of PV types by phylo-
genetic algorithms has presently 111 entries (Bernard
and Chan, 1997).
A separate PV type is defined as having L1 gene
sequences that differ by at least 10% from that of any
other type (van Ranst et al., 1996). On a higher taxonomic
level, PV types form phylogenetic clusters that have been
termed ‘‘groups’’ and ‘‘supergroups.’’ On a lower taxo-
nomic level, there is a small amount of sequence varia-
tion of independent isolates from the original ‘‘prototype’’
isolate, which does not exceed a few percent, and rarely
indicates genomes directly intermediate between exist-
ing PV types. An exception are the two closely related
PVs HPV-18 and HPV-45, where African variants are
more closely related to one another than non-African
isolates.
The largest taxonomic assemblage of PVs is the ‘‘gen-
ital’’ supergroup formed by 68 HPV and monkey PV types,
which can be divided into 15 groups, each of which
unites several closely related viruses (Chan et al., 1997).
The three types, HPV-2, HPV-27, and HPV-57, are the only
members of one of these groups. The prototype of HPV-2
is referred to as HPV-2a, and had originally been de-
tected in a common wart (Orth et al., 1977), but is also
occasionally found in benign and malignant genital and
mucosal lesions (Adler-Storthz et al., 1986; Garlick and
Taichmann, 1991; Obalek et al., 1993). HPV-27 was also
first found in a common wart (Ostrow et al., 1989). A viral
genome initially described as a subtype of HPV-2,
HPV-2c (Fuchs and Pfister, 1984), was later proven to be
identical to HPV-27. By the rules of HPV taxonomy, the
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name HPV-27 now supersedes HPV-2c (Chan et al.,
1994). HPV-57 was originally found in a mucosal lesion
(deVilliers et al., 1989). It turned out to be related to
HPV-2 (Hirsch-Behnam et al., 1990) and, not surprisingly,
was subsequently found most often in skin lesions
(Ru¨bben et al., 1993), including, recently, in a plantar
epidermoid cyst, a lesion normally associated with
HPV-60 (Egawa et al., 1997). A presumed subtype of
HPV-2, HPV-2e (Wilson et al., 1989) is most likely identi-
cal to HPV-57 (Ru¨bben et al., 1993). In summary, HPV-2,
HPV-27, and HPV-57 stand out as being the most com-
monly found viruses in common warts, and they prefer-
entially cause skin lesions despite being evolutionarily
related to those ‘‘genital’’ PVs that normally infect muco-
sal epithelial. Under phylogenetic aspects it is of interest
that no other common HPV types are as closely related
to one another as HPV-2 and HPV-27, whose genomic
sequence diverges by only just about 10%.
The research in this paper had two aims: (i) to discover
any additional member of this PV group that would be
found in common warts, and (ii) to examine the phyloge-
netic pattern of genomic variation in this closely knit
group. Toward these goals, we studied biopsies from
Europe and East Asia, as previous studies of HPV-16 and
HPV-18 had identified differing variants in these parts of
the world. Unfortunately, it was not possible to obtain
material from African patients.
MATERIALS AND METHODS
Origin of biopsies
The DNA samples from Germany were derived from
common wart biopsies of patients attending the Depart-
ment of Dermatology of Rheinisch-Westfa¨lische Tech-
nische Hochschule Aachen and constituted a large frac-
tion of material published previously (Ru¨bben et al.,
1993). The Japanese samples were biopsies of common
warts of patients attending the Department of Dermatol-
ogy, Kumamoto University School of Medicine, Ku-
mamoto, and the Singaporean samples were biopsies of
Chinese patients attending the National Skin Centre and
the Singapore General Hospital. DNA was extracted
from the Japanese and Singaporean samples by stan-
dard procedures. Altogether, we could verify the pres-
ence of HPV-2, HPV-27, or HPV-57 DNA in 48 of 48
German samples, 16 of 46 Japanese samples, and 11 of
21 Singaporean samples. The fairly low success rate in
the cases of the latter two cohorts probably stemmed
from the fact that some of these samples were from
archival sources.
Polymerase chain reaction and DNA sequencing
In previous studies of the genomic diversity of HPV-6,
HPV-11, HPV-16, and HPV-18 (Heinzel et al., 1995; Ho et
al., 1993; Ong et al., 1993), we have amplified homolo-
gous segments of the respective long control region
(LCR) of these viruses, which correspond functionally to
transcriptional enhancers (Chong et al., 1990). These
genomic segments are particularly useful for the phylo-
genetic comparison of variants of individual HPV-types,
as they accumulated larger numbers of mutational
changes than genes (Chan et al., 1992; Yamada et al.,
1995). The LCRs of different HPV types, although com-
posed of homologous cis-responsive elements, have
normally diversified to such an extent that a reliable
alignment is not possible. In contrast, HPV-2, HPV-27,
and HPV-57 are so closely related that enough similari-
ties exist for such an alignment. In fact, we could identify
two flanking sequences with complete identity in all
three viruses and used these sequences for PCR primer
design, namely the sequence 59-CCGTTTTCGGTTGCGT-
GCAG-39 of the upper strand and the sequence 59-GA-
CATTGCGACCGGAATAGG-39 on the lower strand. These
sequences are not included in Fig. 1, which shows the
LCR sequences of HPV-2, HPV27, and HPV-57 bracketed
by these primers. The first G of Fig. 1 corresponds to the
genomic positions 7527 in HPV-2a, 7503 in HPV-27, and
7519 in HPV-57, respectively. The polymerase chain re-
action was performed as described (Ho et al., 1993),
using Taq polymerase mixture with a proofreading ability
(Hifidelity, Boehringer Mannheim, Germany). The PCR
product sequenced directly using the same PCR primers
as sequencing primers.
Evaluation of nucleotide sequences
Phylogenetic analyses were based on multiple align-
ments (PILEUP in the Wisconsin Package, Version 8.1-
UNIX) (Program Manual for the Wisconsin Package,
1994) of the phylogenetically informative segments by
using neighbor-joining and maximum likelihood algo-
rithms in the Phylogeny Inference Package, Version 3.5
(PHYLIP) (Felsenstein, 1982).
Genbank accession numbers
The nucleotide sequences of all HPV-2, 27, and 57
variants have been deposited in GenBank under Acces-
sion Nos. AF026960 to AF026975.
RESULTS
Samples from German patients
We have studied 50 DNA samples from German sam-
ples, which had been described based on the limited
resolving power of restriction fragment polymorphism
analysis (Ru¨bben et al., 1993). We analyzed 48 of these
samples by PCR and direct sequencing, while the two
remaining samples contained a double infection by
HPV-2 and HPV-57. Altogether, 17 samples contained
HPV-2, 11 HPV-27, and 20 HPV-57. In 47 of these 48
samples the classification of the HPV type of the original
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publication could be confirmed, with the exception of the
fact that all samples that were originally classified as
containing HPV-2c were now confirmed to contain HPV-
27. This was expected following the taxonomic correction
of the status of HPV-2c as being identical to the HPV-27
prototype (Chan et al., 1994).
Based on restriction patterns, it had been proposed
that eight of the HPV-2 samples would contain the pro-
totype HPV-2a, and nine a variant HPV-2a-v1. We did not
find any isolate with the exact sequence of HPV-2a, but
eight of the presumed HPV-2a isolates, now termed HPV-
2-G1, were similar to HPV-2a with the exception of a
single point mutation in the LCR segment. Among the
population previously termed HPV-2a-v1, we could dis-
tinguish four different variants, HPV-2-G7, G10, G12, and
G13, which were distinguishable by several point muta-
tions but shared a deletion of one nucleotide at position
7706 and a point mutation at position 7720. As classified
by the LCR sequences, one sample of the HPV-2a group
contained variant HPV-2-G7, and one sample of the HPV-
2a-v1 group variant G1, suggesting the presence of ad-
ditional variation elsewhere in the G1 and G7 genomes.
In contrast to the diversity of HPV-2 variants, all 11
German HPV-27 samples contained viral genomes with
the HPV-27 prototype sequence.
Among the 10 samples presumed to contain HPV-57,
none had the exact HPV-57 prototype sequence, but 9
had a genome with a point mutation at position 7599
(HPV-57-G32). The remaining sample contained a variant
with nine point mutations and a single nucleotide dele-
tion (HPV-57-G42). This same mutational pattern was
found in eight of nine variants originally classified as
HPV-57-v1, which, however, further split up into three
variants due to additional or alternative point mutations.
The presence of one sample each of HPV-57-G32 and
HPV-57-G42 in the HPV-57 prototype group and in the
HPV-57-v1 group suggests additional variation of G1 and
G7 elsewhere in the genome.
The exact sequence data and the abundance of each
variant are summarized in Fig. 1 and Table 1.
Samples from Japanese patients
We also analyzed 50 DNA preparations from common
warts from Japanese patients. We detected HPV DNA
only in 16 of these, most likely, since the DNA was
derived from fixed biopsies and quantitatively or qualita-
tively insufficient for PCR amplification. We found HPV-2
in 5, HPV-27 in 1, and HPV-57 in 10 biopsies. The HPV-2
genomes all contained a single and novel variant, HPV-
2-J10, which differed from the German variant HPV-2-G10
by a single point mutation. HPV-27 was found in a single
patient and had the prototype sequence. HPV-57 was
found in 11, the largest number, of samples. It was de-
tected in the forms of four different genomic variants,
which exhibited a larger diversity than the HPV-2 sam-
ples diversity. Only one of these variants was also found
elsewhere (in Germany and Singapore), the other three
variants being specific for Japan.
Samples from Singaporean patients
The three HPV types under consideration were found
in 11 common warts from Singaporean patients of Chi-
nese race. HPV-2 was found five times as two variants
detected previously in Germany and Japan, and as a
novel variant, HPV-2-S5, which differed from the HPV-2a
prototype by a single point mutation. HPV-27 was found
four times, once in the form of the prototype, and three
times in the form of the variant HPV-2-S12, which differed
from the HPV-27 variation by a single point mutation. Two
warts contained HPV-57 in the form of the variant J5.
In addition to these PCR experiments with specific
primers that would detect HPV-2, HPV-27, and HPV-57,
and very closely related unknown HPV types, all samples
from Singapore and Japan were examined with MY09/
MY11 primers, which have the capacity to detect a large
number of different HPVs (Bernard et al., 1994; Manos et
al., 1989), but evidence for additional HPV genomes was
not found. Also, the German samples had been screened
with general primers as published without detection of
novel HPVs (Ru¨bben et al., 1993).
Phylogenetic analysis of HPV-2, HPV-27, andHPV-57
variants
Figure 2 presents the relationship among all genomic
variants of these three HPV types in the form of a phy-
logenetic tree. We note the large amount of genomic
diversity among HPV-57 variants, and the moderate
amount among HPV-2 isolates, as opposed to the star-
tling similarity among HPV-27 isolates. In spite of the
close relationships in this three-type-cluster, there are no
variants that span a large part of the distance between
any two types, although the one-nucleotide deletion in
some variants of HPV-2 at position 7706 combined with
the G to C mutation at position 7720 could be interpreted
as ‘‘bridging mutations’’ between the prototype genome
of HPV-2 and HPV-27.
FIG. 1. Nucleotide sequence of a segment of the long control region of HPV-2a, HPV-27, and HPV-57, which corresponds functionally to the
epithelial-specific enhancer of papillomaviruses. Position number 1 in this figure corresponds to the genomic position numbers 7527, 7503, and 7519
of HPV-2a, HPV-27, and HPV-57, respectively, in databases of full-length HPV genomes (Myers et al., 1996). The abbreviations G, J, and S refer to
variants that were initially found in patient cohorts from Germany, Japan, and Singapore. Dots refer to the identity of this nucleotide with that of the
corresponding HPV prototype. Hyphens refer to a deletion that occurred either with respect to the corresponding prototype (position 180 5 7706 of
HPV-2a) or in the alignment of HPV-2a, HPV-27, and HPV-57 with one another (all other deletions).
298 CHAN ET AL.
299
DISCUSSION
Our observations reinforce the view that HPV types of
the HPV-2/27/57 group are the principal papillomavi-
ruses associated with common warts. It is of interest that
HPV-27, a little studied type with occasionally mistaken
identity, and HPV-57, which was observed in only a small
number of studies, occur worldwide and are apparently
as abundant as the well-known type HPV-2a. As the
samples from Germany had been examined by low strin-
gency hybridization protocols, and those from Japan and
Singapore by consensus primer PCR conditions, it is
also quite unlikely that additional yet undiscovered HPV
types are frequently prevalent in common warts. It is well
known, however, that common warts are also associated
with HPV types remotely related to the viruses of this
study, in particular with HPV-1, HPV-4, and HPV-7.
Another scope of our study was to determine the
diversity within each HPV type. Previous analyses of the
intratype phylogeny of about 17 different, mostly genital,
HPV types had shown a similar 1 to 5% genomic vari-
ability, often leading to phylogenetic trees with a some-
what dichotomic structure (Heinzel et al., 1995; Ho et al.,
1993; Ong et al., 1993; Kawase et al., 1996; Stewart et al.,
1996; Yamada et al., 1995). In all but one case genomes
intermediate between two types could not be found, the
exception being African variants of HPV-18 and HPV-45
that do bridge part of the genetic distance between the
two types. As the most plausible explanation for these
phenomena we proposed that speciation of HPV types
was an ancient event, most likely predating speciation of
Homo sapiens, with the consequence of extinction of
intermediate genomes between present day HPV types
and their ancestors. We note that this same pattern also
holds true for the HPV-2/27/57 cluster, although the close
relationships, in particular between HPV-2 and HPV-27,
may indicate more recent speciation events. More recent
events of this nature might have increased the likelihood
of finding evolutionary intermediates, but unfortunately,
this was not the case. It should be pointed out that it was
much more difficult during this dermatological study as
opposed to previous analyses of gynecological material
to obtain patient material from many different parts of the
world. In particular, we could not obtain samples from
African patients, which, at least in the case of HPV-16
and HPV-18, showed particularly pronounced genomic
diversity. For the viruses studied here, we noted minimal
genomic variation for HPV-27 and maximal diversity for
HPV-57. The explanation for this is not clear, but this
could be a reflection of the relative age of these three
types, HPV-57 possibly being the oldest type.
Nucleotide changes may lead to mutated viral proteins
or altered cis-responsive elements modulating the viral
life cycle. This consideration led to a recent expansion of
TABLE 1
Distribution and Abundance of HPV-2, HPV-27, and HPV-57 Variants
in Three Patient Cohorts from Germany, Japan, and Singapore
Patient
cohort
Variant: prevalence
HPV-2 HPV-27 HPV-57
German G1: 9/17 Prototype: 11/11 G32: 10/20
G7: 2/17 G42: 2/20
G10: 2/17 G44: 6/20
G12: 3/17 G46: 1/20
G13: 1/17 J5: 1/20
Japanese J10: 5/5 Prototype: 1/1 J3: 1/10
J4: 3/10
J5: 5/10
J21: 1/10
Singapore G12: 1/5 Prototype: 1/4 J5: 2/2
J10: 2/5 S12: 3/4
S5: 2/5
FIG. 2. Phylogenetic tree of HPV-2a, HPV-27, and HPV-57 prototype
and variants. The branch leading to HPV-57 and its variants is shown
by a broken line, since the distance between HPV-57 and the other two
HPV types would exceed the scale of this figure.
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research into the biology and epidemiology of the vari-
ants of HPV types. Probably the most important associ-
ation of unique variants with altered clinical observation
that has been reported is the identification of HPV-16
variants with deletions of transcriptional silencer ele-
ments that occur more frequently in malignant lesions. It
is likely, however, that such variants may have arisen by
mutation and subsequent selection in situ rather than
representing a particular tumorigenic viral subpopulation
(Dong et al., 1994). The existence of subpopulations of
functionally divergent viruses was suggested by studies
of different genomic regions of HPV-16 and HPV-18
(Hecht et al., 1995; Xi et al., 1997). A problem with these
research approaches is that it is difficult or impossible to
pinpoint a cause, i.e., the particular genomic alteration
responsible for a changed viral pathology. This makes an
epidemiological approach necessary with its require-
ment to study viral association in very large numbers of
lesions. It would be desirable, for example, to examine
whether or not HPV-2, 27, and 57 variants from mucosal
lesions, which were not available for this study, would be
genetically different from those variants in common
warts. One does not necessarily have to expect such
differences. To give an example, a subtype of HPV-57,
termed HPV-57b, had been described from intranasal
neoplasia (Wu et al., 1993, Trujillo et al., 1996). While the
data of these publications support the identification of
HPV-57 in a large number of nasal lesions, they do not
support a distinction between the prototype (HPV-57a)
and this presumed new subtype. Our reexamination of
the published nucleotide sequence of HPV-57b (Trujillo
et al., 1996) identifies the HPV-57b genome as similar
and probably even identical to our variant HPV-57-G44,
which, together with its close relatives G42 and G46, is
one of the most common PV genomes in common skin
warts.
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